HIV Post-Exposure Prophylaxis (PEP) Guidelines

Download PDF
Therapeutic Guidelines Menu

For information on how to obtain medication for prevention of HIV infection following a high risk occupational or non-occupational exposure, please call the St Paul’s Hospital Ambulatory Pharmacy 1-888-511-6222

 

  • This guideline is intended to guide health care providers caring for persons who have experienced significant exposure to blood and/or body fluids in the work place or community setting. The risk of HIV acquisition from a given exposure depends on the likelihood the source has transmissible HIV infection, and the biological risk of HIV transmission based on the exposure that has occurred.
  • This guideline is designed to deal specifically with exposures to Human Immunodeficiency Virus (HIV) and is not applicable to other exposures such as viral hepatitis.
  • This guideline provides a framework for a program of expert advice and prompt antiretroviral post-exposure prophylaxis (PEP) for potential exposures to HIV.
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search